Novartis
Executive Summary
David Epstein named chief operating officer of Novartis Pharmaceuticals Corporation, reporting to CEO Wayne Yetter. Epstein, who joined Sandoz in 1989 as a new product manager, was previously head of product and customer businesses. That position will be eliminated. Epstein co-chaired the U.S. and Canadian Pharma Steering Committees overseeing the integration of Ciba and Sandoz in 1996. Epstein holds an MBA from Columbia University and was an associate with Booz, Allen and Hamilton before joining Sandoz